Status:
RECRUITING
Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT
Lead Sponsor:
Yu Shi
Conditions:
Diagnose Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Patients who visited our hospital for various reasons from January 2024, underwent CT scans involving the pancreas, and were eligible for spectral post-processing reconstruction were included in the s...
Detailed Description
Dual-Energy CT (DECT) is a widely recognized technology, especially in its applications for the abdominal and pelvic regions. Pancreatology is an ideal application of the many advantages offered by du...
Eligibility Criteria
Inclusion
- Since March 2024, I have been visiting our hospital for various reasons and have undergone CT scans involving the pancreas (using energy spectrum CT)
Exclusion
- Previous pancreatic surgery with incomplete pancreatic tissue.
- Severe systemic diseases that result in severe organ dysfunction
- Excessive pancreatic atrophy or other reasons cannot accurately delineate ROI
Key Trial Info
Start Date :
January 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 21 2028
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06510036
Start Date
January 21 2021
End Date
June 21 2028
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004